Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PLC Backs Away From PMR; CardioGenesis Continues To Seek PMA Approval

This article was originally published in The Gray Sheet

Executive Summary

Heart laser manufacturers CardioGenesis and PLC Medical Systems are pursuing divergent approaches to product development in the wake of an unfavorable panel review for CardioGenesis' PMR percutaneous myocardial revascularization system.
Advertisement

Related Content

CardioGenesis’ PMR On Deck For FDA Dispute Resolution Panel Review
CardioGenesis’ PMR On Deck For FDA Dispute Resolution Panel Review
CardioGenesis Data From 900 Additional Patients May Push PMR Over Top
CardioGenesis Data From 900 Additional Patients May Push PMR Over Top
CardioGenesis
CardioGenesis
PMR Adverse Events, Elusive Efficacy Endpoints Cited In Panel Rejection
PMR Adverse Events, Elusive Efficacy Endpoints Cited In Panel Rejection
Edwards/PLC Medical Deal Shows Confidence in Laser Angina Therapy
Advertisement
UsernamePublicRestriction

Register

MT015218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel